Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Emergent BioSolutions, Inc.

https://www.emergentbiosolutions.com/

Latest From Emergent BioSolutions, Inc.

2020 Sees Sharp Rise In EU New Drug Approvals

The number of new drugs containing new active substances approved in the EU rose significantly in 2020, underpinned by a strong showing for orphan-designated products and a string of novel medicines for cancer and infectious diseases. Notable among the new clutch of approvals was the first ever COVID-19 vaccine, Pfizer/BioNTech's Comirnaty.

Europe Approvals

Kinnate Raises $98m To Take Kinase Inhibitors Into The Clinic

The company’s next-generation kinase inhibitors are designed to target unaddressed mutations and overcome treatment resistance. Lead programs focus on BRAF Class II and III mutations and FGFR2/3.

Financing Business Strategies

Convalescent Plasma EUA Will Not Complicate Hyperimmune Globulin Product Development, Sponsors Say

US FDA authorization will further boost already-high demand for plasma from individuals recovered from COVID-19 and increase competition for donors, NYU’s Arthur Caplan predicts, but CoVIg-19 Plasma Alliance and Emergent BioSolutions say they do not expect EUA to impact either product supply or enrollment in upcoming randomized trials of their H-Ig products.

Coronavirus COVID-19 Clinical Trials

As Other US Agencies Respond To The Pandemic, FEMA Fine-Tunes Plan Of Action

Industry wonders how emergency agency's COVID-19 public-private partnerships will fit in with the others.

Coronavirus COVID-19 Manufacturing
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • Vaccines
  • Biotechnology
    • Large Molecule
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Adapt Pharma Limited
    • Aptevo Therapeutics
    • BioPort Corporation
    • Cangene Corporation
    • Trubion Pharmaceuticals, Inc.
    • PaxVax Corporation
UsernamePublicRestriction

Register